Mxi2 promotes stimulus-independent ERK nuclear translocation

EMBO Journal

Volumn 26, Issue 3, 2007, Pages 635-646

  Casar, Berta ^a   Sanz Moreno, Victoria ^a   Yazicioglu, Mustafa N ^b   Rodríguez, Javier ^a   Berciano, María T ^a   Lafarga, Miguel ^a   Cobb, Melanie H ^b   Crespo, Piero ^a,c  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

ERK; MAP kinases; Mxi2; Nuclear import; p38

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MXI2 PROTEIN; NUCLEOPORIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; STIMULUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHOPROTEINS; RNA INTERFERENCE;

EID: 33846981476     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601523     Document Type: Article

References (30)

1. Adachi M, Fukuda M, Nishida E (1999) Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 18: 5347-5358
2. Adachi M, Fukuda M, Nishida E (2000) Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol 148: 849-856
3. Ajenjo N, Canon E, Sanchez-Perez I, Matallanas D, Leon J, Perona R, Crespo P (2004) Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells. J Biol Chem 279: 32813-32823
4. Bardwell AJ, Flatauer LJ, Matsukuma K, Thorner J, Bardwell L (2001) A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. J Biol Chem 276: 10374-10386
5. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8: 1049-1057
6. Blanco-Aparicio C, Torres J, Pulido R (1999) A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J Cell Biol 147: 1129-1136
7. Burack WR, Shaw AS (2005) Live Cell Imaging of ERK and MEK: simple binding equilibrium explains the regulated nucleocytoplasmic distribution of ERK. J Biol Chem 280: 3832-3837
8. Callaway K, Rainey MA, Dalby KN (2005) Quantifying ERK2-protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains. Biochim Biophys Acta 1754: 316-323
9. Esparis-Ogando A, Diaz-Rodriguez E, Montero JC, Yuste L, Crespo P, Pandiella A (2002) Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 22: 270-285
10. Finlay DR, Newmeyer DD, Price TM, Forbes DJ (1987) Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J Cell Biol 104: 189-200
11. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B, Nguyen XT, Barnier JV, Camonis J, Ginsberg MH, Chneiweiss H (2001) PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1: 239-250
12. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E (1997a) CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390: 308-311
13. Fukuda M, Gotoh Y, Nishida E (1997b) Interaction of MAP kinase with MAP kinase kinas: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J 16: 1901-1908
14. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13: 163-175
15. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, Cobb MH (1998) Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93: 605-615
16. Lee T, Hoofnagle AN, Kabuyama Y, Stroud J, Min X, Goldsmith EJ, Chen L, Resing KA, Ahn NG (2004) Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol Cell 14: 43-55
17. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J (1993) Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol 122: 1079-1088
18. Matsubayashi Y, Fukuda M, Nishida E (2001) Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J Biol Chem 276: 41755-41760
19. Pearson G, Robinson F, Gibson TG, Xu B, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Revs 22: 153-183
20. Pouyssegur J, Lenormand P (2003) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270: 3291-3299
21. Ranganathan A, Yazicioglu MN, Cobb MH (2006) The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy. J Biol Chem 281: 15645-15652
22. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH (1995) Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92: 8881-8885
23. Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH (1998) A constitutively active and nuclear form of MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8: 1141-1150
24. Sanz V, Arozarena I, Crespo P (2000) Distinct carboxi-termini confer divergent characteristics to the mitogen-activated protein kinase p38a and its splice isoform Mxi2. FEBS Lett 474: 169-174
25. Sanz-Moreno V, Casar B, Crespo P (2003) p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol Cell Biol 23: 3079-3090
26. Shapiro PS, Vaisberg E, Hunt AJ, Tolwinski NS, Whalen AM, McIntosh JR, Ahn NG (1998) Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen. J Cell Biol 142: 1533-1545
27. Whitehurst AW, Robinson FL, Moore MS, Cobb MH (2004) The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem 279: 12840-12847
28. Whitehurst AW, Wilsbacher JL, You Y, Luby-Phelps K, Moore MS, Cobb MH (2002) ERK2 enters the nucleus by a carrier-independent mechanism. Proc Natl Acad Sci USA 99: 7496-7501
29. Wolf I, Rubinfeld H, Yoon S, Marmor G, Hanoch T, Seger R (2001) Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J Biol Chem 276: 24490-24497
30. Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R (1995) Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates max protein. Proc Natl Acad Sci USA 92: 10531-10534